🔍

Nexus Surgical And Medicare Ltd (538874)

📊 BSE: 538874 🏢 Other Financial Services 📢 Latest filing: 26 Sep 2026

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Nexus Surgical's revenue was ₹2.5 Cr (+47.3% year on year, +24.3% on the previous quarter), and net profit ₹0.2 Cr (+36.1% year on year); the operating margin was 9.7%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹2.5	+47.3%	+24.3%
Operating profit	₹0.2	+23.1%	-18.0%
Net profit	₹0.2	+36.1%	-14.9%
EPS (₹)	0.37	+37.0%	-15.9%
Operating margin	9.7%	—	—

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Nexus Surgical Appoints Anish More as MD for 3 Years at ₹24 Lakh Annual Remuneration

🟡 NEUTRAL ⭐ 7/10

MANAGEMENT 📅 26 Sep 2026, 04:34 PM

Shareholders of Nexus Surgical and Medicare Ltd approved the appointment of Mr. Anish More as Managing Director at the 35th AGM on September 25, 2026. His 3-year term runs from September 2, 2026 to September 1, 2029, with an approved annual remuneration of ₹24,00,000 (₹0.24 crore). This annual pay equals roughly 24% of the company's TTM net profit of ₹1 crore, sanctioned under Schedule V due to inadequate profits. Mr. More brings a background in computer engineering, cloud infrastructure, and healthcare technology startups.

Appointment of Mr. Anish More approved as Managing Director for a 3-year term from September 2, 2026 to September 1, 2029
Annual remuneration set at ₹24,00,000 under Schedule V of the Companies Act, 2013 due to inadequate profits
Remuneration of ₹0.24 crore represents ~24% of the company's TTM PAT of ₹1 crore
Approval granted at the 35th AGM held on September 25, 2026 via video conferencing

💡 Track upcoming quarterly filings and operational commentary to see if the new leadership drives strategic expansion in healthcare tech or improves operating margins.

Nexus Surgical & Medicare Schedules Board Meeting on Sept 2, 2026 for 35th AGM Matters

🟡 NEUTRAL ⭐ 2/10

BOARD_MEETING 📅 25 Aug 2026, 05:44 PM

Nexus Surgical and Medicare Limited has scheduled a meeting of its Board of Directors on Wednesday, September 2, 2026. The agenda includes considering and approving the Directors' Report for the financial year ended March 31, 2026. Additionally, the board will finalize the date, notice, book closure dates, and e-voting cut-off for the upcoming 35th Annual General Meeting (AGM). The company, with a market capitalization of approximately ₹11 crore, is executing standard annual compliance procedures.

Board meeting scheduled for September 2, 2026 at 03:00 p.m.
Agenda to approve Directors' Report for the FY ended March 31, 2026
Fixing date, time, and notice for the 35th Annual General Meeting
Setting cut-off date and book closure for AGM e-voting
Appointment of scrutinizer for AGM e-voting process

💡 Track the upcoming AGM notice and annual report publication to review management's commentary and full audited annual accounts.

Nexus Surgical Q1 Results: Revenue Grows 47% YoY to ₹2.55 Cr, PAT at ₹0.20 Cr

🟢 POSITIVE ⭐ 6/10

EARNINGS 📅 13 Aug 2026, 05:47 PM

Nexus Surgical and Medicare reported a strong 47.7% YoY growth in revenue for Q1 FY27, reaching ₹2.55 Cr. Net profit followed with a 33.9% YoY increase to ₹20.42 lakhs, although it saw a sequential decline from ₹23.99 lakhs in the March 2026 quarter. The company's performance was tempered by a significant 101% surge in 'Other expenses', which rose to ₹1.66 Cr. Given its micro-cap status (₹10 Cr market cap), these results represent a material portion (~32%) of its trailing twelve-month revenue.

Revenue from operations increased to ₹2.55 Cr from ₹1.73 Cr in the same quarter last year.
Net profit for the quarter stood at ₹20.42 lakhs, up from ₹15.25 lakhs YoY.
Other expenses doubled YoY, rising from ₹82.43 lakhs to ₹165.97 lakhs.
Earnings Per Share (EPS) improved to ₹0.37 from ₹0.28 in the year-ago period.
Total expenses for the quarter rose 51% YoY to ₹2.30 Cr.

💡 Investors should monitor the trend in 'Other expenses' to see if the current margin pressure is temporary or structural as the company scales its trading operations.

Nexus Surgical Q1 FY27 Net Profit up 34% YoY to ₹0.20 Cr; Revenue grows 48%

🟢 POSITIVE ⭐ 6/10

EARNINGS 📅 13 Aug 2026, 05:45 PM

Nexus Surgical reported a strong 47.7% YoY increase in revenue to ₹2.55 Cr for the quarter ended June 30, 2026. Net profit grew 33.9% YoY to ₹0.20 Cr, although it saw a sequential decline of 14.9% from the March 2026 quarter. The company's profitability was impacted by a significant rise in 'Other expenses', which surged to ₹1.66 Cr from ₹0.82 Cr in the year-ago period. Despite the growth, the company remains a micro-cap with a market capitalization of only ₹10 Cr and a low promoter holding of 18.7%.

Revenue from operations increased 47.7% YoY to ₹2.55 Cr compared to ₹1.73 Cr in Q1 FY26.
Net profit for the quarter stood at ₹20.42 lakhs, up from ₹15.25 lakhs in the same quarter last year.
Other expenses rose sharply to ₹1.66 Cr, accounting for nearly 64% of total income.
Earnings Per Share (EPS) for the quarter was ₹0.37, compared to ₹0.28 in the previous year's corresponding quarter.
The company remains debt-free with a total equity capital of ₹5.47 Cr.

💡 Investors should monitor the sustainability of the revenue growth and investigate the nature of 'Other expenses' which are currently consuming a large portion of the top line.

Nexus Surgical to consider Q1 FY27 results on August 13, 2026

🟡 NEUTRAL ⭐ 3/10

BOARD_MEETING 📅 08 Aug 2026, 04:56 PM

Nexus Surgical and Medicare Ltd has scheduled a board meeting for August 13, 2026, to approve unaudited financial results for the quarter ended June 30, 2026. The company, a micro-cap with a market capitalization of Rs 10 Cr, reported a TTM revenue of Rs 8 Cr and a net profit of Rs 1 Cr. Investors should note the low promoter holding of 18.73% and the company's small net worth of Rs 2 Cr. The trading window for designated persons remains closed until August 15, 2026.